APREA THERAPEUTICS ANNOUNCES AGREEMENT WITH MD ANDERSON CANCER CENTER TO EXPLORE APR-1051 AS A POTENTIAL TREATMENT FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)

Reuters · 03/11 12:33

Please log in to view news